BRCA2 and cancer: Combining a PARP inhibitor with hyperthermia showed good treatment efficacy for cancers with HR deficiency.528 Gregory et al. showed that YU238259, an inhibitor of DNA DSB repair, has synergistic effects with ionizing radiation and PARP inhibition, and that this synergism is enhanced with BRCA2 deficiency.